/4892.T
4892.T Stock - Cyfuse Biomedical K.K.
Healthcare|Drug Manufacturers - Specialty & GenericJPX
$588.00+6.91%
+$38.00 (+6.91%) • Dec 24
52
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.23
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.58
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $646.80
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for 4892.T
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$582.12 – $593.88
TARGET (TP)$676.20
STOP LOSS$540.96
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.55
52W High$1412.00
52W Low$433.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $54.45M | $61.11M | $374.48M | $708.25M | $137.48M |
| Gross Profit | $16.45M | $37.74M | $241.50M | $570.60M | $67.02M |
| Gross Margin | 30.2% | 61.8% | 64.5% | 80.6% | 48.7% |
| Operating Income | $-896,133,000 | $-697,437,000 | $-425,089,000 | $70.57M | $-372,135,000 |
| Net Income | $-872,238,000 | $-589,211,000 | $-473,962,000 | $142.91M | $-329,501,000 |
| Net Margin | -1602.0% | -964.1% | -126.6% | 20.2% | -239.7% |
| EPS | $-108.31 | $-75.42 | $-177.67 | $285.52 | $-46.12 |
Company Overview
Cyfuse Biomedical K.K. engages in the development, manufacture, and sale of regenerative medicine products in Japan. It develops cellular products in the field of regenerative therapy; and undertakes contract for cellular products for research and development. The company also offers Bio 3D Printer for use in the regeneration of various tissues and organs, such as cartilage and bones, blood vessels, and nerves; regenova, a bio 3D printer for 3D stacking of cells; and S-PIKE that develops 3D-structures from cells. Cyfuse Biomedical K.K. was incorporated in 2010 and is based in Tokyo, Japan.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
4892.TBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-25.83
Q4 2025
EPS Surprise History
Q3 23
No data
Q1 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q1 25
No data
Q2 25
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 14, 2025 | — | $-25.83 | — | — |
Q3 2025 | Aug 14, 2025 | — | — | — | — |
Q2 2025 | May 15, 2025 | — | $-19.90 | — | — |
Q1 2025 | Feb 14, 2025 | — | $-25.56 | — | — |
Q4 2024 | Nov 14, 2024 | — | $-26.68 | — | — |
Q3 2024 | Aug 14, 2024 | — | $-27.77 | — | — |
Q2 2024 | May 15, 2024 | — | $-28.38 | — | — |
Q1 2024 | Feb 14, 2024 | — | $-6.98 | — | — |
Q3 2023 | Sep 30, 2023 | — | $-21.74 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-25.16 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-21.56 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-25.93 | — | — |
Q3 2022 | Sep 30, 2022 | — | $-21.97 | — | — |
Latest News
Loading news...
Frequently Asked Questions about 4892.T
What is 4892.T's current stock price?
Cyfuse Biomedical K.K. (4892.T) is currently trading at $588.00 per share. The stock has moved +6.91% today.
What is the analyst price target for 4892.T?
No analyst price targets are currently available for this stock.
What sector is Cyfuse Biomedical K.K. in?
Cyfuse Biomedical K.K. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the JPX exchange.
What is 4892.T's market cap?
Cyfuse Biomedical K.K. has a market capitalization of $5.22 billion, making it a mid-cap company.
Does 4892.T pay dividends?
No, Cyfuse Biomedical K.K. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare Sector206A.T
PRISM BioLab Co.,LTD
$148.00
Mkt Cap: $5.4B
4539.T
Nippon Chemiphar Co., Ltd.
$1542.00
Mkt Cap: $5.6B
4556.T
KAINOS Laboratories, Inc.
$1264.00
Mkt Cap: $5.3B
4576.T
D. Western Therapeutics Institute, Inc.
$93.00
Mkt Cap: $4.1B
4582.T
SymBio Pharmaceuticals Limited
$89.00
Mkt Cap: $4.3B
4598.T
Delta-Fly Pharma, Inc.
$500.00
Mkt Cap: $5.7B
4882.T
Perseus Proteomics Inc.
$220.00
Mkt Cap: $3.2B
4883.T
Modalis Therapeutics Corporation
$55.00
Mkt Cap: $4.2B
7079.T
WDB coco Co., Ltd.
$2670.00
Mkt Cap: $6.4B
7707.T
Precision System Science Co., Ltd.
$182.00
Mkt Cap: $4.9B
Explore stocks similar to 4892.T for comparison